Literature DB >> 3430099

Differential effects of L-propionylcarnitine on the electrical and mechanical properties of guinea pig ventricular muscle in normal and acidic conditions.

M Aomine1, M Arita.   

Abstract

We studied the effects of L-propionylcarnitine (PC) on transmembrane action potentials and isometric contractile tension in isolated guinea pig ventricular papillary muscles. The effects of 5 concentrations of PC (10(-5), 10(-4), 10(-3), 10(-2) and 3 X 10(-2)M) were examined in both normal (pH 7.4) and acidic (pH 6.9) conditions. The concentrations of 10(-5) to 10(-2)M had no significant effect on action potential amplitude, maximum upstroke velocity of phase 0 and resting potential, in either condition. At pH 7.4, action potential duration (ADP) was significantly (P less than 0.05) or insignificantly shortened by the drug depending upon the concentration used. At pH 6.9, however, the APD was prolonged by moderate PC concentrations (10(-3) and 10(-2)M), in which the effective refractory period (ERP) was also lengthened, associated with an increased ERP/APD ratio. In both pH conditions, the highest concentration (3 X 10(-2)M) significantly (P less than 0.05) decreased all these action potential parameters. PC had a biphasic effect on the developed tension. In both pH conditions, low PC concentrations (10(-5) to 10(-3)M) produced an initial augmentation of the contraction, followed by subsequent reduction. The initial augmentation disappeared by pretreatment with reserpine or propranolol, suggesting the involvement of beta-adrenoceptors. In the steady state, all PC concentrations produced a negative inotropic effect at pH 7.4, while at pH 6.9 only high concentrations (10(-2)M and 3 X 10(-2)M) had this effect. These results suggest that the effects of PC in an acidic condition differ considerably from those in a normal pH condition and that limited concentrations of PC (10(-3) to 10(-2)M) may prevent re-entrant arrhythmias from developing under acidic conditions via lengthening of the ERP, without deleterious effects on the contractile force.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3430099     DOI: 10.1016/s0022-0736(87)80079-1

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  6 in total

1.  Biochemical profile of propionyl-L-carnitine.

Authors:  W C Hülsmann
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium.

Authors:  K A Yamada; D J Dobmeyer; E M Kanter; S G Priori; P B Corr
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

3.  Lack of correlation between the antiarrhythmic effect of L-propionylcarnitine on reoxygenation-induced arrhythmias and its electrophysiological properties.

Authors:  M Barbieri; P U Carbonin; E Cerbai; G Gambassi; P Lo Giudice; I Masini; A Mugelli; M Pahor
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

4.  Effects of propionate on mechanical and metabolic performance in aerobic rat hearts.

Authors:  H Bolukoglu; S H Nellis; A J Liedtke
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

5.  Protection of the ischemic diabetic heart by L-propionylcarnitine therapy.

Authors:  D J Paulson; A L Shug; J Zhao
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

6.  Effects of L-propionylcarnitine on electrical and mechanical alterations induced by amphiphilic lipids in isolated guinea pig ventricular muscle.

Authors:  M Aomine; M Arita; T Shimada
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.